Dilantha B.
Ellegala, MD, FAANS Joins the Newly Created Advisory Board of
Xcelerate, Inc.
MAULDIN, SC
-- February 8, 2021 -- InvestorsHub NewsWire
-- Xcelerate, Inc (OTC:
"UDHI") is pleased to announce that Dr. Dilan Ellegala has
accepted an invitation to join its Advisory Board, effective
immediately. A University of Virginia trained neurosurgeon and
former Harvard Clinical Instructor, Dr. Ellegala is an academician,
medical inventor, and entrepreneur, with in-depth knowledge of
med-tech commercialization.
Dr. Ellegala has been at the
forefront of clinical care and medical technology development for
two decades. An honors graduate of the University of
Washington School of Medicine, he served academic leadership roles
as Director of Neurotrauma and Cerebrovascular Neurosurgery at
major universities, a founding Dean for Global Health, and has had
collaborations with the Wellman Center for Photomedicine at
MIT/Harvard, Clemson Bioengineering, and private industry. He
has authored over 50 peer reviewed research publications and holds
multiple patent claims in ultrasound technology. Dr.
Ellegala,
has successfully
commercialized medical technology and applied it to advance
clinical care. He has founded several successful medical
companies including Sonospine LLC, a pioneer in ultrasonic spine
surgery, and a virtual health company recently acquired by AdviNOW,
LLC which applies artificial intelligence to healthcare.
Dr. Ellegala has received
numerous academic and clinical honors and has been consistently
recognized for his excellence in patient care. In addition to his
pioneering work in the US, he is a testament to the
transformational power of teaching and the ever-present potential
for change in the world, as demonstrated through his training of
health care workers in remote Tanzania to perform brain and spine
surgery. His groundbreaking work in global medical education is
documented in the book, "A Surgeon in the Village: An American
Doctor Teaches Brain Surgery in Africa", which was written by
Pulitzer-nominated journalist Tony Bartleme. NBC's Tom Brokaw
described the work as "A lyrical, inspirational and altogether
rewarding account of first- and third-world surgeons working
together to perform neurosurgery miracles in the heart of
Africa."
"This is truly a great day for
Xcelerate," said Michael O'Shea, Xcelerate' s CEO. "Adding a world
class surgeon and medical technology innovator with incredible
business savvy and people skills to our Advisory Board is exactly
what we've been seeking to transition to our next phase of business
development. Dr. Ellegala is a true humanitarian who is blessed
with an abundance of innate goodness. I am honored to have him join
our team and look forward to utilizing all of his extraordinary
talents and abilities to aide us in our ongoing acquisition and
product development efforts."
To interview
either
Dr. Ellegala
or
O'Shea, contact Dilara Tuncer at
941-549-3571;
dilara@transmediagroup.com.
SAFE HARBOR
This press
release may contain forward-looking information within the meaning
of Section 21E of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), including all statements that are not
statements of historical fact regarding the intent, belief or
current expectations of the Company, its directors or its officers
with respect to, among other things: (i) the Company's financing
plans; (ii) trends affecting the Company's financial condition or
results of operations; (iii) the Company's growth strategy and
operating strategy; and (iv) the declaration and payment of
dividends. The words "may," "would," "will," "expect," "estimate,"
"anticipate," "believe," "intend," and similar expressions and
variations thereof are intended to identify forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company's
ability to control, and that actual results may differ materially
from those projected in the forward-looking statements as a result
of various factors.
Media Contact:
Dilara Tuncer
941-549-3571;
dilara@transmediagroup.com.